Bioconjugate Chemistry, volume 28, issue 9, pages 2485-2492

Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties

Baranski Ann-Christin 1
Schäfer Martin 1
Bauder-Wüst Ulrike 1
Wacker Anja 1
Schmidt Jana 1
Liolios Christos 1
Mier Walter 2
Haberkorn Uwe 2
Eisenhut Michael 3
Kopka Klaus 4
Eder Matthias 5
1
 
German Cancer Research Center (dkfz
3
 
Imaging and Radiooncology
5
 
Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK) Freiburg, Department of Nuclear Medicine, Faculty of Medicine, Medical Center − University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany
Publication typeJournal Article
Publication date2017-08-24
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.7
ISSN10431802, 15204812
Organic Chemistry
Pharmacology
Pharmaceutical Science
Biotechnology
Bioengineering
Biomedical Engineering
Abstract
68Ga-Glu-urea-Lys-(Ahx)-HBED-CC (68Ga-PSMA-11) represents a successful radiopharmaceutical for PET/CT imaging of prostate cancer. Further optimization of the tumor-to-background contrast might significantly enhance the sensitivity of PET/CT imaging and the probability of detecting recurrent prostate cancer at low PSA values. This study describes the advantage of histidine (H)/glutamic acid (E) and tryptophan (W)/glutamic acid (E) containing linkers on the pharmacokinetic properties of 68Ga-PSMA-11. The tracers were obtained by a combination of standard Fmoc-based solid-phase synthesis and copper(I)-catalyzed azide–alkyne cycloaddition. Their 68Ga complexes were compared to the clinical reference 68Ga-PSMA-11 with respect to cell binding, effective internalization, and tumor targeting properties in LNCaP-bearing balb/c nu/nu mice. The introduction of (HE)i (i = 1–3) or (WE)i (i = 1–3) into PSMA-11 resulted in a significantly changed biodistribution profile. The uptake values in kidneys, spleen, liver, and ...

Citations by journals

1
2
3
4
5
Journal of Nuclear Medicine
Journal of Nuclear Medicine, 5, 11.9%
Journal of Nuclear Medicine
5 publications, 11.9%
Molecules
Molecules, 3, 7.14%
Molecules
3 publications, 7.14%
Pharmaceutics
Pharmaceutics, 3, 7.14%
Pharmaceutics
3 publications, 7.14%
Bioconjugate Chemistry
Bioconjugate Chemistry, 3, 7.14%
Bioconjugate Chemistry
3 publications, 7.14%
Cancers
Cancers, 2, 4.76%
Cancers
2 publications, 4.76%
Molecular Pharmaceutics
Molecular Pharmaceutics, 2, 4.76%
Molecular Pharmaceutics
2 publications, 4.76%
Synlett
Synlett, 2, 4.76%
Synlett
2 publications, 4.76%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 2.38%
Journal of Medicinal Chemistry
1 publication, 2.38%
Recent Results in Cancer Research
Recent Results in Cancer Research, 1, 2.38%
Recent Results in Cancer Research
1 publication, 2.38%
Australian Journal of Chemistry
Australian Journal of Chemistry, 1, 2.38%
Australian Journal of Chemistry
1 publication, 2.38%
International Journal of Pharmaceutics
International Journal of Pharmaceutics, 1, 2.38%
International Journal of Pharmaceutics
1 publication, 2.38%
Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces, 1, 2.38%
Colloids and Surfaces B: Biointerfaces
1 publication, 2.38%
Bioorganic Chemistry
Bioorganic Chemistry, 1, 2.38%
Bioorganic Chemistry
1 publication, 2.38%
European Journal of Cancer
European Journal of Cancer, 1, 2.38%
European Journal of Cancer
1 publication, 2.38%
Current Opinion in Chemical Biology
Current Opinion in Chemical Biology, 1, 2.38%
Current Opinion in Chemical Biology
1 publication, 2.38%
Nuclear Medicine and Biology
Nuclear Medicine and Biology, 1, 2.38%
Nuclear Medicine and Biology
1 publication, 2.38%
Journal of Labelled Compounds and Radiopharmaceuticals
Journal of Labelled Compounds and Radiopharmaceuticals, 1, 2.38%
Journal of Labelled Compounds and Radiopharmaceuticals
1 publication, 2.38%
Advanced healthcare materials
Advanced healthcare materials, 1, 2.38%
Advanced healthcare materials
1 publication, 2.38%
Chemical Reviews
Chemical Reviews, 1, 2.38%
Chemical Reviews
1 publication, 2.38%
Journal of Organic Chemistry
Journal of Organic Chemistry, 1, 2.38%
Journal of Organic Chemistry
1 publication, 2.38%
Organic Letters
Organic Letters, 1, 2.38%
Organic Letters
1 publication, 2.38%
Chemical Science
Chemical Science, 1, 2.38%
Chemical Science
1 publication, 2.38%
Cancer Research
Cancer Research, 1, 2.38%
Cancer Research
1 publication, 2.38%
Communications Chemistry
Communications Chemistry, 1, 2.38%
Communications Chemistry
1 publication, 2.38%
New Journal of Chemistry
New Journal of Chemistry, 1, 2.38%
New Journal of Chemistry
1 publication, 2.38%
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 1, 2.38%
European Journal of Nuclear Medicine and Molecular Imaging
1 publication, 2.38%
Pharmaceuticals
Pharmaceuticals, 1, 2.38%
Pharmaceuticals
1 publication, 2.38%
Frontiers in Chemistry
Frontiers in Chemistry, 1, 2.38%
Frontiers in Chemistry
1 publication, 2.38%
1
2
3
4
5

Citations by publishers

1
2
3
4
5
6
7
8
9
American Chemical Society (ACS)
American Chemical Society (ACS), 9, 21.43%
American Chemical Society (ACS)
9 publications, 21.43%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 21.43%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 21.43%
Elsevier
Elsevier, 6, 14.29%
Elsevier
6 publications, 14.29%
Society of Nuclear Medicine and Molecular Imaging
Society of Nuclear Medicine and Molecular Imaging, 5, 11.9%
Society of Nuclear Medicine and Molecular Imaging
5 publications, 11.9%
Springer Nature
Springer Nature, 3, 7.14%
Springer Nature
3 publications, 7.14%
Wiley
Wiley, 2, 4.76%
Wiley
2 publications, 4.76%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 4.76%
Royal Society of Chemistry (RSC)
2 publications, 4.76%
Thieme
Thieme, 2, 4.76%
Thieme
2 publications, 4.76%
CSIRO Publishing
CSIRO Publishing, 1, 2.38%
CSIRO Publishing
1 publication, 2.38%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 1, 2.38%
American Association for Cancer Research (AACR)
1 publication, 2.38%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.38%
Frontiers Media S.A.
1 publication, 2.38%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Baranski A. et al. Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties // Bioconjugate Chemistry. 2017. Vol. 28. No. 9. pp. 2485-2492.
GOST all authors (up to 50) Copy
Baranski A., Schäfer M., Bauder-Wüst U., Wacker A., Schmidt J., Liolios C., Mier W., Haberkorn U., Eisenhut M., Kopka K., Eder M. Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties // Bioconjugate Chemistry. 2017. Vol. 28. No. 9. pp. 2485-2492.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.bioconjchem.7b00458
UR - https://doi.org/10.1021%2Facs.bioconjchem.7b00458
TI - Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties
T2 - Bioconjugate Chemistry
AU - Baranski, Ann-Christin
AU - Schäfer, Martin
AU - Bauder-Wüst, Ulrike
AU - Wacker, Anja
AU - Schmidt, Jana
AU - Haberkorn, Uwe
AU - Eisenhut, Michael
AU - Kopka, Klaus
AU - Mier, Walter
AU - Eder, Matthias
AU - Liolios, Christos
PY - 2017
DA - 2017/08/24 00:00:00
PB - American Chemical Society (ACS)
SP - 2485-2492
IS - 9
VL - 28
SN - 1043-1802
SN - 1520-4812
ER -
BibTex |
Cite this
BibTex Copy
@article{2017_Baranski,
author = {Ann-Christin Baranski and Martin Schäfer and Ulrike Bauder-Wüst and Anja Wacker and Jana Schmidt and Uwe Haberkorn and Michael Eisenhut and Klaus Kopka and Walter Mier and Matthias Eder and Christos Liolios},
title = {Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties},
journal = {Bioconjugate Chemistry},
year = {2017},
volume = {28},
publisher = {American Chemical Society (ACS)},
month = {aug},
url = {https://doi.org/10.1021%2Facs.bioconjchem.7b00458},
number = {9},
pages = {2485--2492},
doi = {10.1021/acs.bioconjchem.7b00458}
}
MLA
Cite this
MLA Copy
Baranski, Ann-Christin, et al. “Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties.” Bioconjugate Chemistry, vol. 28, no. 9, Aug. 2017, pp. 2485-2492. https://doi.org/10.1021%2Facs.bioconjchem.7b00458.
Found error?